Editorial
Editor-in-Chief eMediNexus – Dr KK Aggarwal
 
3rd October 2019

Ranitidine Recall: Time to know that other drugs do not have NDMA

Dr KK Aggarwal, Recipient of Padma Shri

On September 13, 2019, the US FDA announced that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in ranitidine, a heartburn medication. Novartis (through its generic division, Sandoz) and Apotex announced that they were recalling all of their generic ranitidine products sold in the US. GSK has also recalled its ranitidine medication sold in global markets including in India.

Ranitidine is an H2 (or histamine-2) blocker and is commonly used to relieve and prevent heartburn or to treat and prevent more serious ulcers in the stomach and intestines....read more


First-time pregnancy complications linked to increased risk of future hypertension

Dr KK Aggarwal, Recipient of Padma Shri

(Excerpts from NIH): Women who experience complications such as preterm births and preeclampsia during their first pregnancy are nearly twice more likely than women without complications to develop high blood pressure later in life — some as quickly as three years later, according to a new study of more than 4,000 women. The study was published in the Journal of the American Heart Association. It was funded largely by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health...read more

Practice Updates

Government plans penicillin revival to fight rheumatic fever

In a bid to fight drug resistance and tackle rheumatic heart disease, the Government of India is planning a revival of penicillin, one of the oldest antibiotics known to man. Not many organisms have developed resistance to it yet... read more


PAHO Director urges faster progress toward universal health in the Americas

The goal of "universal health" should be within reach in the Americas – a region that has been a world leader in health progress. But stepped-up action and investments are needed to speed progress toward universal health, said the Director of the Pan American Health Organization (PAHO), Carissa F. Etienne, during the opening ceremony of the 57th PAHO Directing Council.... read more


Experimental prostate cancer therapy delays disease in 'landmark' trial

An experimental prostate cancer therapy may change the way patients are treated for the second-deadliest cancer in men. In a "landmark" phase III clinical trial, presented at the European Society of Medical Oncology... read more


Canagliflozin approved for preventing HF hospitalization in T2D

The FDA has approved new cardiovascular and renal prevention indications for canagliflozin (Invokana), according to a statement from the Janssen unit of Johnson & Johnson. The SGLT-2 inhibitor is now indicated for preventing end-stage kidney disease,... read more


Prediagnosis exercise protective against CVD after breast cancer

Older women who exercised prior to a diagnosis of breast cancer may have a lower risk of cardiovascular events (CVEs) and mortality from cardiovascular disease (CVD) compared with those who did not engage in exercise, a new analysis from the Women's Health Initiative (WHI) suggests.... read more

IDEJ Update

Indian Diabetes Educator Journal (IDEJ), 1st of its kind in India aims to keep the members of diabetes care team abreast with concepts of DSME (Diabetes self-management education) and DSMS (Diabetes self-management support). IDEJ has set a new benchmark in educating the diabetes educators about evolving the concept of DSME- reaching to more than 25000 through Digital and Print Medium..... read more

eMedi Humor
Medicolegal Corner
eMedi Quiz
1. The sample should be kept at 4°C.
2. The sample should be incubated at 37°C.
3. The sample should be refrigerated in deep freezer.
4. The sample should be refrigerated for the initial 3 hours and then incubated at 37°C.
Lifestyle Updates
 
Inspirational Story 1: The way to feel good is to do good.
Inspirational Story 2: A new pair of shoes
"To watch 1500+ such videos, please visit www.medtalks.in"